Health Care & Life Sciences » Biotechnology | Chiome Bioscience Inc.

Chiome Bioscience Inc.

Chiome Bioscience Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY61.6
Market Cap
JPY7.41 B
Shares Outstanding
32.77 M
Public Float
24.59 M

Profile

Address
Sumitomo Fudosan Nishi-Shinjuku Bldg
Tokyo Tokyo 151
Japan
Employees -
Website http://www.chiome.co.jp
Updated 07/08/2019
Chiome Bioscience, Inc. engages in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) System. Its operations are carried out through Innovative Drug and Innovative Drug Support business segments. The Innovative Drug segment manufactures specific antibodies based on new antigen mechanisms and licenses these out to pharmaceutical industries.

Financials

View All
Created with Highcharts 5.0.14Chiome Bioscience Inc.Net Income. Fiscal year is January-December. All values JPY Thousands.426 890426 8901 150 2981 150 2981 282 7141 282 7141 491 1621 491 162882 570882 5701 533 5021 533 5022013201420152016201720180500k1 000k1 500k2 000k
Created with Highcharts 5.0.14Chiome Bioscience Inc.Sales/Revenue. Fiscal year is January-December. All values JPY Thousands.324 127324 127370 344370 344280 113280 113252 215252 215259 895259 895212 851212 8512013201420152016201720180100k200k300k400k

Shigeru Kobayashi
President & Representative Director
Zaigen Bijodaira
Director & Manager-Corporate Planning